Atorvastatin administered daily versus every other day in patients with dyslipidaemia or coronary artery disease on a stable atovastatin dose

Trial Profile

Atorvastatin administered daily versus every other day in patients with dyslipidaemia or coronary artery disease on a stable atovastatin dose

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Jul 2012

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Coronary artery disease; Dyslipidaemias
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top